Insufficient tricuspid regurgitation to quantify pulmonary artery pressure

Making Health Care Personal
Our Vision: The world leader in advancing personalized health
Our Mission: Personalizing the patient experience through our caring spirit and distinctive capabilities

Vanderbilt University Medical Center is committed to principles of equal opportunity and affirmative action. EOE/AA/Women/Minority/Vets/Disabled

Copyright ©2022 by Vanderbilt University Medical Center

Vanderbilt®, Vanderbilt University Medical Center®, V Oak Leaf Design®, Monroe Carell Jr. Children’s Hospital at Vanderbilt® and Vanderbilt Health® are trademarks of The Vanderbilt University.

Clinical Investigation

Pulmonary Hemodynamics

Pulmonary Artery Acceleration Time Provides an Accurate Estimate of Systolic Pulmonary Arterial Pressure during Transthoracic Echocardiography

Background

Transthoracic echocardiographic estimates of peak systolic pulmonary artery pressure are conventionally calculated from the maximal velocity of the tricuspid regurgitation (TR) jet. Unfortunately, there is insufficient TR to determine estimated peak systolic pulmonary artery pressure (EPSPAP) in a significant number of patients. To date, in the absence of TR, no noninvasive method of deriving EPSPAP has been developed.

Methods

Five hundred clinically indicated transthoracic echocardiograms were reviewed over a period of 6 months. Patients with pulmonic stenosis were excluded. Pulsed-wave Doppler was used to measure pulmonary artery acceleration time (PAAT) and right ventricular ejection time. Continuous-wave Doppler was used to measure the peak velocity of TR (TRVmax), and EPSPAP was calculated as 4 × TRVmax2 + 10 mm Hg (to account for right atrial pressure). The relationship between PAAT and EPSPAP was then assessed.

Results

Adequate imaging to measure PAAT was available in 99.6% of patients (498 of 500), but 25.3% (126 of 498) had insufficient TR to determine EPSPAP, and 1 patient had significant pulmonic stenosis. Therefore, 371 were included in the final analysis. Interobserver variability for PAAT was 0.97. There were strong inverse correlations between PAAT and TRVmax (r = −0.96), the right atrial/right ventricular pressure gradient (r = −0.95), and EPSPAP (r = −0.95). The regression equation describing the relationship between PAAT and EPSPAP was log10(EPSPAP) = −0.004 (PAAT) + 2.1 (P < .001).

Conclusions

PAAT is routinely obtainable and correlates strongly with both TRVmax and EPSPAP in a large population of randomly selected patients undergoing transthoracic echocardiography. Characterization of the relationship between PAAT and EPSPAP permits PAAT to be used to estimate peak systolic pulmonary artery pressure independent of TR, thereby increasing the percentage of patients in whom transthoracic echocardiography can be used to quantify pulmonary artery pressure.

Section snippets

Methods

All aspects of this study were approved by our institutional review board (Partner’s Human Research Committee). Five hundred (of a total of 9,200) clinically indicated transthoracic echocardiographic studies performed in the Massachusetts General Hospital echocardiography laboratory over a 6-month period (March to September 2009) were randomly selected for retrospective review. To arrive at this total number of participants, a research staff member who was blinded to patient age, gender, and

Results

Among this cohort of randomly selected clinical studies, pulsed-wave Doppler imaging of the main pulmonary artery was sufficient to measure PAAT in 99.6% of patients (498 of 500). In contrast, 25.2% (126 of 500) did not have sufficient TR to measure TRVmax. One individual was excluded from analysis because of the presence of significant pulmonary valve stenosis. As such, 371 individuals were retained in the final analysis.

In the final cohort (n = 317), the mean age was 63 ± 17 years (range,

Discussion

TTE has proven to be an important tool in the noninvasive assessment of pulmonary artery pressures in a wide spectrum of illnesses.6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 The most widely accepted transthoracic method for the estimation of pulmonary artery pressures relies on the measurement of TRVmax. However, TR is frequently not sufficient to perform this measurement, as demonstrated by the fact that 25% of patients in our randomly selected clinical cohort had insufficient TR for

Conclusions

We have shown that PAAT is easily obtainable and strongly correlated with TRVmax in a large population of randomly selected patients undergoing TTE. Characterization of the relationship between PAAT and EPSPAP now permits PAAT to be used to derive EPSPAP independently of TR. Adoption of this novel method of determining EPSPAP has the capacity to significantly increase the percentage of patients in which TTE can be used to quantify pulmonary artery pressures.

References (27)

  • et al.

    Variable effects of changes in flow rate through the aortic, pulmonary and mitral valves on valve area and flow velocity: impact on quantitative Doppler flow calculations

    J Am Coll Cardiol

    (1985)

  • D. Mutlak et al.

    Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity?

    Chest

    (2009)

  • J.T. Beard et al.

    Saline contrast enhancement of trivial Doppler tricuspid regurgitation signals for estimating pulmonary artery pressure

    Am J Cardiol

    (1988)

  • F. Torres et al.

    Echocardiographic contrast increases the yield for right ventricular pressure measurement by Doppler echocardiography

    J Am Soc Echocardiogr

    (1989)

  • A.D. Waggoner et al.

    Saline contrast enhancement of tricuspid regurgitant jets detected by Doppler color flow imaging

    Am J Cardiol

    (1990)

  • R. Syyed et al.

    The relationship between the components of pulmonary artery pressure remains constant under all conditions in both health and disease

    Chest

    (2008)

  • D. Chemla et al.

    New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure

    Chest

    (2004)

  • M. McGoon et al.

    Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

    Chest

    (2004)

  • J.G. Stevenson

    Comparison of several noninvasive methods for estimation of pulmonary artery pressure

    J Am Soc Echocardiogr

    (1989)

  • L. Lanzarini et al.

    Noninvasive estimation of both systolic and diastolic pulmonary artery pressure from Doppler analysis of tricuspid regurgitant velocity spectrum in patients with chronic heart failure

    Am Heart J

    (2002)

Cited by (120)

Recommended articles (6)

View full text

Copyright © 2011 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

What does insufficient tricuspid regurgitation signal mean?

(Tricuspid Insufficiency; Tricuspid Incompetence) Tricuspid regurgitation (TR) is insufficiency of the tricuspid valve causing blood flow from the right ventricle to the right atrium during systole. The most common cause is dilation of the right ventricle.

Is tricuspid regurgitation related to pulmonary hypertension?

Introduction: Tricuspid valve regurgitation (TR) is a frequent finding in patients with pulmonary arterial hypertension (PAH).

Should I worry about mild tricuspid regurgitation?

Mild tricuspid valve regurgitation may not cause symptoms or require treatment. If the condition is severe and causing signs and symptoms, medications or surgery may be needed.

Can you have pulmonary hypertension without tricuspid regurgitation?

In a population of patients referred for right heart catheterization, pulmonary hypertension was present in nearly half (47%) of all patients with an absence of a measurable tricuspid regurgitation velocity.

Related Posts

Toplist

Latest post

TAGs